Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RLYB compared with VYNE: revenue, margins and what each company keeps, and the suppliers and customers both name
RLYB
Rallybio Corp
Change
Mkt cap
Revenue
Revenue
VYNE
VYNE Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RLYB
Rallybio Corp
vs
VYNE
VYNE Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RLYB, solid
VYNE, dashed
RLYB
Rallybio Corp
Change
16.08
▲
+2.49%
· post 15.69
Mkt cap
$84.8M
Revenue
$212,000
Q1 FY26
Revenue
$858,000
FY25
VYNE
VYNE Therapeutics Inc.
Change
15.49
▲
+13.93%
· post 15.50
Closed
Nov 6 '26
Mkt cap
—
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
RLYB
Rallybio Corp
vs
VYNE
VYNE Therapeutics Inc.
16.08
▲
+2.49%
post 15.69
Price
15.49
▲
+13.93%
post 15.50
$84.8M
Mkt cap
—
Q1 FY26
$212,000
Revenue
—
FY25
$858,000
Revenue
—
Change
Change
RLYB
16.08
▲
+2.49%
vs
VYNE
15.49
▲
+13.93%
Closed
Nov 6 '26